Product Information
LOTEPREDNOL 0.5% OPHTHALMC GEL is a generic product labeled by ARMAS PHARMACEUTICALS INC., priced at $18.1880 per GM under NDC 72485063005. Its NADAC has been published 121 times since Jun 12, 2024.
FDA first approved this application on Feb 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/g
Manufacturer
ARMAS PHARMACEUTICALS INC.NDC
72485063005
Classification
Generic
Dosage Form
GEL
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
Generic (ANDA)
FDA Application
ANDA212080FDA Approved
2/10/2021
TE Code
AB
On Market Since
10/25/2023
Pharmacological Classes
Price Statistics
The NADAC for LOTEPREDNOL 0.5% OPHTHALMC GEL has been published 121 times since Jun 12, 2024, and over the history we have for it it has declined 21.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.1880 per GM |
|---|---|
| All-time high | $28.2217 (Oct 16, 2024) |
| All-time low | $14.0549 (Jun 18, 2025) |
| 52-week high | $18.1880 |
| 52-week low | $14.2657 |
| Median price | $15.3228 |
| Average price | $17.2265 |
| Largest weekly change | -37.4% (Nov 20, 2024) |
| Weeks tracked | 121 |
| Tracking since | Jun 12, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Loteprednol Etabonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ARMAS PHARMACEUTICALS INC. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loteprednol Etabonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOTEPREDNOL 0.5% OPHTHALMC GEL?
The current National Average Drug Acquisition Cost (NADAC) for LOTEPREDNOL 0.5% OPHTHALMC GEL, manufactured by ARMAS PHARMACEUTICALS INC., is $18.1880 per GM (NDC 72485063005), effective Sep 30, 2026.
How has the price of LOTEPREDNOL 0.5% OPHTHALMC GEL changed over time?
Over the history we have for it, the NADAC for LOTEPREDNOL 0.5% OPHTHALMC GEL has declined 21.4%. It has been tracked across 121 weekly CMS publications since Jun 12, 2024.
What are the highest and lowest recorded NADAC prices for LOTEPREDNOL 0.5% OPHTHALMC GEL?
Since Jun 12, 2024, the NADAC for LOTEPREDNOL 0.5% OPHTHALMC GEL has ranged from a low of $14.0549 (Jun 18, 2025) to a high of $28.2217 (Oct 16, 2024), with a median of $15.3228 per GM.
Are there cheaper alternatives to LOTEPREDNOL 0.5% OPHTHALMC GEL?
No other NADAC-published product currently shares the active ingredient and strength of LOTEPREDNOL 0.5% OPHTHALMC GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOTEPREDNOL 0.5% OPHTHALMC GEL?
LOTEPREDNOL 0.5% OPHTHALMC GEL (NDC 72485063005) is labeled by ARMAS PHARMACEUTICALS INC., and CMS classifies it as a generic product.